21 Hrs
Source:
The Guardian
The Guardian
Ready to play
Ready to play
A study suggests that a monoclonal antibody called apitegromab may help prevent muscle loss in people using weight-loss drugs like tirzepatide. The trial found participants taking apitegromab retained significantly more lean body mass compared to those on placebo, though the study was small and short-term. Experts emphasize the need for larger trials to confirm safety and health benefits, while advising increased physical activity to help maintain muscle during weight loss.
Notice: This Is an AI-Generated Summary
Comments (0)